Literature DB >> 23263475

Multiple sclerosis imaging: recent advances.

Maria A Rocca1, Roberta Messina, Massimo Filippi.   

Abstract

In this review, we summarize advances in knowledge derived from the application of magnetic resonance imaging (MRI)-based techniques to patients with multiple sclerosis (MS) published in the Journal of Neurology over the past year. We highlight the pivotal role played by conventional MRI techniques for a correct and early diagnosis of this condition and the exclusion of alternative disorders. Advanced MR methods have contributed to demonstrating how damage to selected brain structures is related to disease clinical manifestations, thus contributing to overcome the well-known "clinical-radiological" paradox of MS, and ameliorating the understanding of the mechanisms underlying the accumulation of irreversible disability. Finally, we discuss the use of MRI to assess treatment efficacy and optimize therapeutic approaches in this condition.

Entities:  

Mesh:

Year:  2012        PMID: 23263475     DOI: 10.1007/s00415-012-6788-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  54 in total

Review 1.  A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.

Authors:  Christopher Eckstein; Shiv Saidha; Michael Levy
Journal:  J Neurol       Date:  2011-09-20       Impact factor: 4.849

Review 2.  Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?

Authors:  Douglas S Goodin
Journal:  Ann Neurol       Date:  2006-04       Impact factor: 10.422

3.  Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

Authors:  M Filippi; M Rovaris; M A Rocca; M P Sormani; J S Wolinsky; G Comi
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

4.  Evolution of MS lesions to black holes under DNA vaccine treatment.

Authors:  Athina Papadopoulou; Stefanie von Felten; Stefan Traud; Amena Rahman; Joanne Quan; Robert King; Hideki Garren; Lawrence Steinman; Gary Cutter; Ludwig Kappos; Ernst Wilhelm Radue
Journal:  J Neurol       Date:  2012-01-06       Impact factor: 4.849

5.  Fatigue and progression of corpus callosum atrophy in multiple sclerosis.

Authors:  Özgür Yaldizli; Stephanie Glassl; Dietrich Sturm; Athina Papadopoulou; Achim Gass; Barbara Tettenborn; Norman Putzki
Journal:  J Neurol       Date:  2011-05-19       Impact factor: 4.849

6.  Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials.

Authors:  F Barkhof; M Filippi; D H Miller; P Tofts; L Kappos; A J Thompson
Journal:  J Neurol       Date:  1997-02       Impact factor: 4.849

7.  Assessing the value of spinal cord lesions in predicting development of multiple sclerosis in patients with clinically isolated syndromes.

Authors:  L Patrucco; J I Rojas; E Cristiano
Journal:  J Neurol       Date:  2011-12-17       Impact factor: 4.849

8.  Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.

Authors:  Eva Havrdova; Steven Galetta; Michael Hutchinson; Dusan Stefoski; David Bates; Chris H Polman; Paul W O'Connor; Gavin Giovannoni; J Theodore Phillips; Fred D Lublin; Amy Pace; Richard Kim; Robert Hyde
Journal:  Lancet Neurol       Date:  2009-02-07       Impact factor: 44.182

9.  Progressive multifocal leukoencephalopathy after natalizumab monotherapy.

Authors:  Hans Lindå; Anders von Heijne; Eugene O Major; Caroline Ryschkewitsch; Johan Berg; Tomas Olsson; Claes Martin
Journal:  N Engl J Med       Date:  2009-09-10       Impact factor: 91.245

Review 10.  Management of acute optic neuritis.

Authors:  S J Hickman; C M Dalton; D H Miller; G T Plant
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  10 in total

1.  Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.

Authors:  J Maranzano; M Dadar; D A Rudko; D De Nigris; C Elliott; J S Gati; S A Morrow; R S Menon; D L Collins; D L Arnold; S Narayanan
Journal:  AJNR Am J Neuroradiol       Date:  2019-06-20       Impact factor: 3.825

Review 2.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

Review 3.  Some recent advances in multiple sclerosis.

Authors:  Claire McCarthy; John Thorpe
Journal:  J Neurol       Date:  2016-04-25       Impact factor: 4.849

4.  Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.

Authors:  Martina Absinta; Luisa Vuolo; Anuradha Rao; Govind Nair; Pascal Sati; Irene C M Cortese; Joan Ohayon; Kaylan Fenton; María I Reyes-Mantilla; Dragan Maric; Peter A Calabresi; John A Butman; Carlos A Pardo; Daniel S Reich
Journal:  Neurology       Date:  2015-04-17       Impact factor: 9.910

5.  Clinical Profile and the Extent of Disability in Multiple Sclerosis Patients in Madinah, Saudi Arabia.

Authors:  Esraa Q Alsaedi; Marwa Q Alsaedi; Farah A Mansuri
Journal:  Cureus       Date:  2022-06-11

6.  In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis.

Authors:  In-Young Choi; Phil Lee; Peter Adany; Abbey J Hughes; Scott Belliston; Douglas R Denney; Sharon G Lynch
Journal:  Mult Scler       Date:  2017-06-01       Impact factor: 6.312

7.  Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.

Authors:  Guillaume Bonnier; Alexis Roche; David Romascano; Samanta Simioni; Djalel Meskaldji; David Rotzinger; Ying-Chia Lin; Gloria Menegaz; Myriam Schluep; Renaud Du Pasquier; Tilman Johannes Sumpf; Jens Frahm; Jean-Philippe Thiran; Gunnar Krueger; Cristina Granziera
Journal:  Ann Clin Transl Neurol       Date:  2014-06-03       Impact factor: 4.511

8.  Functional Magnetic Resonance Imaging Correlations Between Fatigue and Cognitive Performance in Patients With Relapsing Remitting Multiple Sclerosis.

Authors:  Dessislava Iancheva; Anastasya Trenova; Stefka Mantarova; Kiril Terziyski
Journal:  Front Psychiatry       Date:  2019-10-29       Impact factor: 4.157

9.  Secondary progressive and relapsing remitting multiple sclerosis leads to motor-related decreased anatomical connectivity.

Authors:  Mark Lyksborg; Hartwig R Siebner; Per S Sørensen; Morten Blinkenberg; Geoff J M Parker; Anne-Marie Dogonowski; Ellen Garde; Rasmus Larsen; Tim B Dyrby
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

Review 10.  Gray matters in multiple sclerosis: cognitive impairment and structural MRI.

Authors:  Silvia Messina; Francesco Patti
Journal:  Mult Scler Int       Date:  2014-01-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.